Skip to main content
. 2019 Sep 16;13(6):1091–1100. doi: 10.1093/ckj/sfz118

FIGURE 1.

FIGURE 1

(A) Kaplan–Meier plot of patient survival of ESP-KTRs. ESP-KTRs show a median patient survival after kidney transplantation of 86 months. (B) Kaplan–Meier plot of patient survival between male ESP-KTRs and female ESP-KTRs. Male ESP-KTRs showed significantly inferior long-term patient survival compared with female ESP-KTRs (P = 0.012). While no differences were observed for the first 2.5 years post-transplantation, median patient survival after kidney transplantation was 80 months for male ESP-KTRs versus 131 months for female ESP-KTRs. (C) Kaplan–Meier plot of patient survival between donor–recipient gender mismatch groups. No differences are shown for patient survival between male recipients from male donors versus male recipients (Log rank: P = 0.390), and female recipients from female donors versus female recipients from male donor (Log rank: P = 0.188). (D) Kaplan–Meier plot of death-censored allograft survival of ESP-KTRs. ESP-KTRs show primary non-function in 3.7% of cases and a 5- and 10-year death-censored allograft survival of 83 and 70%. (E) Kaplan–Meier plot of death-censored allograft survival between male ESP-KTRs and female ESP-KTRs. No differences are shown for death-censored allograft survival between male ESP-KTRs and female ESP-KTRs. (F) Kaplan–Meier plot of death-censored allograft survival between donor–recipient gender mismatch groups. No differences are shown for death-censored allograft survival between donor–recipient gender mismatch groups. (G) Kaplan–Meier plot of uncensored allograft survival of ESP-KTRs. ESP-KTRs show a median uncensored kidney allograft survival of 73 months. (H) Kaplan–Meier plot of uncensored allograft survival between male ESP-KTRs and female ESP-KTRs. Male ESP-KTRs show a tendency for inferior uncensored allograft survival compared with female ESP-KTRs with a median of 61 versus 82 months.